E-ISSN 2277-338X
 

Original Research
Online Published: 29 Aug 2019
 


Bevacizumab with paclitaxel and carboplatin for locally advanced (Stage IIIB) metastatic adenocarcinoma of lung: A feasibility study from tertiary care center

.


Abstract
No abstract available


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

. Bevacizumab with paclitaxel and carboplatin for locally advanced (Stage IIIB) metastatic adenocarcinoma of lung: A feasibility study from tertiary care center. Int J Med Sci Public Health. 2019; 8(10): 877-880. doi:10.5455/ijmsph.2019.0823026082019


Web Style

. Bevacizumab with paclitaxel and carboplatin for locally advanced (Stage IIIB) metastatic adenocarcinoma of lung: A feasibility study from tertiary care center. https://www.ijmsph.org/?mno=61772 [Access: October 12, 2025]. doi:10.5455/ijmsph.2019.0823026082019


AMA (American Medical Association) Style

. Bevacizumab with paclitaxel and carboplatin for locally advanced (Stage IIIB) metastatic adenocarcinoma of lung: A feasibility study from tertiary care center. Int J Med Sci Public Health. 2019; 8(10): 877-880. doi:10.5455/ijmsph.2019.0823026082019



Vancouver/ICMJE Style

. Bevacizumab with paclitaxel and carboplatin for locally advanced (Stage IIIB) metastatic adenocarcinoma of lung: A feasibility study from tertiary care center. Int J Med Sci Public Health. (2019), [cited October 12, 2025]; 8(10): 877-880. doi:10.5455/ijmsph.2019.0823026082019



Harvard Style

(2019) Bevacizumab with paclitaxel and carboplatin for locally advanced (Stage IIIB) metastatic adenocarcinoma of lung: A feasibility study from tertiary care center. Int J Med Sci Public Health, 8 (10), 877-880. doi:10.5455/ijmsph.2019.0823026082019



Turabian Style

. 2019. Bevacizumab with paclitaxel and carboplatin for locally advanced (Stage IIIB) metastatic adenocarcinoma of lung: A feasibility study from tertiary care center. International Journal of Medical Science and Public Health, 8 (10), 877-880. doi:10.5455/ijmsph.2019.0823026082019



Chicago Style

. "Bevacizumab with paclitaxel and carboplatin for locally advanced (Stage IIIB) metastatic adenocarcinoma of lung: A feasibility study from tertiary care center." International Journal of Medical Science and Public Health 8 (2019), 877-880. doi:10.5455/ijmsph.2019.0823026082019



MLA (The Modern Language Association) Style

. "Bevacizumab with paclitaxel and carboplatin for locally advanced (Stage IIIB) metastatic adenocarcinoma of lung: A feasibility study from tertiary care center." International Journal of Medical Science and Public Health 8.10 (2019), 877-880. Print. doi:10.5455/ijmsph.2019.0823026082019



APA (American Psychological Association) Style

(2019) Bevacizumab with paclitaxel and carboplatin for locally advanced (Stage IIIB) metastatic adenocarcinoma of lung: A feasibility study from tertiary care center. International Journal of Medical Science and Public Health, 8 (10), 877-880. doi:10.5455/ijmsph.2019.0823026082019